Pharmabiz18h
Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease
GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant ...
Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by MAI Capital Management
MAI Capital Management lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 6.7% in the ...
Swiss National Bank Sells 600 Shares of Abercrombie & Fitch Co. (NYSE:ANF)
Swiss National Bank lowered its stake in shares of Abercrombie & Fitch Co. (NYSE:ANF – Free Report) by 0.6% during the third ...